from Reuters: Health News https://ift.tt/2ItzRFT
Insmed's treatment-resistant lung disease drug gets FDA approval
The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.
from Reuters: Health News https://ift.tt/2ItzRFT
from Reuters: Health News https://ift.tt/2ItzRFT
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment